Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Ligand Pharma (LGND) Ownership - Who Owns Ligand Pharma?
782 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 17, 2024 | xxxxxxxxxxxxx | $1146657 | |
| May 17, 2024 | Nancy Ryan Gray Director | xxxxxxxxxxxxx | $77709 |
| May 15, 2024 | Matthew Korenberg President & Chief Operating | xxxxxxxxxxxxx | $1495692 |
| May 13, 2024 | Andrew Reardon Clo & | xxxxxxxxxxxxx | $830400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $355046 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1105564 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $3901858 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,227,383 | Institution | 12.40% | 222,203,728 | |
| 1,737,964 | Institution | 9.67% | 173,379,289 | |
| 1,454,427 | Institution | 8.10% | 145,093,638 | |
| 1,265,918 | Insider | 7.05% | 126,287,980 | |
| 912,488 | Institution | 5.08% | 91,029,803 | |
| 737,917 | Institution | 4.11% | 73,614,600 | |
| 425,658 | Institution | 2.37% | 42,463,642 | |
| 417,695 | Insider | 2.33% | 41,669,253 | |
| 377,308 | Institution | 2.10% | 37,640,246 | |
| 325,961 | Institution | 1.81% | 32,517,869 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,454,427 | Institution | 8.10% | 145,093,638 | |
| 912,488 | Institution | 5.08% | 91,029,803 | |
| 737,917 | Institution | 4.11% | 73,614,600 | |
| 425,658 | Institution | 2.37% | 42,463,642 | |
| 377,308 | Institution | 2.10% | 37,640,246 | |
| 325,961 | Institution | 1.81% | 32,517,869 | |
| 255,208 | Institution | 1.42% | 25,459,550 | |
| 209,157 | Institution | 1.16% | 20,865,502 | |
| 180,491 | Institution | 1.00% | 18,005,782 | |
| 167,410 | Institution | 0.93% | 16,700,822 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,102,892 | Institution | 6.14% | 110,024,506 | |
| 456,952 | Institution | 2.54% | 45,585,532 | |
| 529,203 | Institution | 2.95% | 44,590,645 | |
| 428,958 | Institution | 2.39% | 36,144,001 | |
| 288,671 | Institution | 1.61% | 24,323,418 | |
| 254,112 | Institution | 1.41% | 21,411,477 | |
| 184,675 | Institution | 1.03% | 18,423,178 | |
| 158,402 | Institution | 0.88% | 15,802,184 | |
| 145,664 | Institution | 0.81% | 14,414,909 | |
| 129,916 | Institution | 0.72% | 12,960,420 |
FAQ
Who Owns Ligand Pharma (LGND)?
Currently, no data Available
What percentage of Ligand Pharma (LGND) stock is held by institutional investors?
Currently, no data Available
What percentage of Ligand Pharma (LGND) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ligand Pharma (LGND)?
iShares owns the most shares of Ligand Pharma (LGND).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.